Skip to content

Sublingual Microcirculation of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope

Population Research of Sublingual Microcirculation Data of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02412839
Enrollment
150
Registered
2015-04-09
Start date
2015-04-30
Completion date
2017-02-28
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study will enroll 150 healthy volunteers, and the grouping is as follows: group 20-39 (30 males and 30 females); group 40-59 (30 males and 30 females); and group 60-79 (15 males and 15 females). The sublingual microcirculation will be examined with the incident dark field video microscope (Cytocam,Braedius Battery Powered Transilluminator). The study aims to compare the differences of microcirculation among the three groups and between genders.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers aged from 20 to 79 years old * BMI ranged from 18.5 to 27 kg/m2

Exclusion criteria

* Systolic blood pressure \> 140 mm Hg, diastolic blood pressure \> 95 mm Hg, or systolic blood pressure \< 90 mm Hg at enrollment * Body temperature \> 37.5 ℃ or \< 35.5 ℃ at enrollment * had been diagnose with any one of the following diseases * hypertension * diabetes mellitus * peripheral arterial occlusive disease * coronary arterial disease * liver cirrhosis * chronic kidney disease * stroke * anemia * asthma * chronic bronchitis * any metabolic diseases * any hematologic disease * uncured cancer * chronic uncontrolled infection * other disease may limit daily activities * non-native speakers

Design outcomes

Primary

MeasureTime frameDescription
Total small vessel density of sublingual small vessels measured by CytocamOnce at enrollmentTotal small vessel density will be measured by Cytocam

Secondary

MeasureTime frameDescription
Perfused small vessel density of sublingual small vessels measured by CytocamOnce at enrollmentPerfused small vessel density will be measured by Cytocam

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026